publication date: Mar. 23, 2018

Conversation with the Cancer Letter NYU’s Caplan: Right to Try laws are meaningless, empty hot air, unethical, and utterly ineffective Arthur_L_Caplan1

Arthur L. Caplan

Drs. William F. and Virginia Connolly Mitty Professor,

Founding director of the Division of Medical Ethics,

New York University School of Medicine

 

The right-to-try bills passed by Congress would remove FDA’s expanded access mandate and leave patients at greater risk, said Arthur Caplan, the Drs. William F. and Virginia Connolly Mitty Professor and founding director of the Division of Medical Ethics at the New York University School of Medicine.

“Not only am I saying [right-to-try] is meaningless and empty hot air, we at NYU have a counter effort that we’ve done, to try and incentivize and work with companies,” Caplan said. “The only way to understand this FDA animus that Goldwater has is that they’re on an anti-regulatory kick, because the other number that we established pretty clearly is that the FDA approved somewhere between 99.4 and 99.6 percent of company-granted requests.

“The FDA is happy to sign off, as long as the company is willing to … Continue reading NYU’s Caplan: Right to Try laws are meaningless, empty hot air, unethical, and utterly ineffective

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.